Laurel Wealth Advisors (California)’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.14M Sell
15,343
-1,780
-10% -$121K 0.11% 191
2022
Q3
$1.02M Buy
17,123
+5,183
+43% +$312K 0.11% 205
2022
Q2
$670K Hold
11,940
0.07% 291
2022
Q1
$881K Sell
11,940
-38
-0.3% -$2.64K 0.07% 264
2021
Q4
$865K Buy
+11,978
New +$870K 0.07% 300

Other funds holding GMED

Laurel Wealth Advisors (California)'s GMED Position: Q4 2022 in Review

Laurel Wealth Advisors (California) reduced its Globus Medical (GMED) stake by 10% in Q4 2022, selling an estimated $121K and leaving 15,343 shares worth $1.14M. The position accounts for 0.11% of the portfolio, ranked #191.

Laurel Wealth Advisors (California) first reported a position in GMED in Q4 2021 and has held it in 5 quarters since. 390 funds tracked by Wall St. Rank hold GMED as of Q4 2022.

  • Laurel Wealth Advisors (California) held 15,343 shares of Globus Medical worth $1.14M as of Q4 2022.
  • Laurel Wealth Advisors (California) sold 1,780 Globus Medical shares in Q4 2022, an estimated $121K.
  • Globus Medical made up 0.11% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #191 holding.
  • Laurel Wealth Advisors (California) first reported a position in Globus Medical in Q4 2021 and has held it in 5 quarters since.
  • 390 funds tracked by Wall St. Rank held Globus Medical as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.